Eddie is an expert in the field of Hematology. He studied medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care He received 2 awards: "Meaningful Use Stage 1 Certification" and "Super Doctor". Eddie is a published doctor. He published 3 publications, including: 'A phase II trial of docetaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (TORI B01).' Dr. Eddie H. Hu is registered with Medicare.
NPI NUMBER | 1871537738 | |
NPPES Provider LastName | HU | |
NPPES Provider FirstName | EDDIE | |
NPPES Provider ZIPCode | 918014438 | |
NPPES Provider State | CA | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 4654.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 150.0 | |
Percent Opioid Claims | 3.22 |
National Provider Identifier [NPI] | 1871537738 |
Last Name Of The Provider | HU |
First Name Of The Provider | EDDIE |
View All |
Dr. Steven H. Applebaum, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Evangelia K. Kirimis, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Mark V. McNamara, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Ming T. Chong, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Brit S. Shackley, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Cynthia L. Martel, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Yi-Kong Keung, MD | |
Dr. Mark N. Samonte, MD
This Doctor is OpenDoctor Recommended. |